Published in J Immunol on March 15, 2001
Photoaffinity antigens for human gammadelta T cells. J Immunol (2008) 1.19
Herpes simplex virus 1 glycoprotein B and US3 collaborate to inhibit CD1d antigen presentation and NKT cell function. J Virol (2011) 1.01
Human CD1d knock-in mouse model demonstrates potent antitumor potential of human CD1d-restricted invariant natural killer T cells. Proc Natl Acad Sci U S A (2013) 0.94
Old game, new players: Linking classical theories to new trends in transplant immunology. World J Transplant (2017) 0.75
Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med (1995) 6.26
Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med (2000) 6.15
Helper T cell differentiation is controlled by the cell cycle. Immunity (1998) 5.71
Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J Exp Med (1993) 4.80
Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature (1998) 4.10
Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice. Immunity (1997) 3.74
Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells. J Exp Med (1997) 3.74
Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytolytic T lymphocytes. Nature (1989) 3.49
Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist. Cancer Res (1999) 2.96
Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science (1998) 2.76
H-2M3 presents a Listeria monocytogenes peptide to cytotoxic T lymphocytes. Cell (1992) 2.70
Maternally transmitted histocompatibility antigen of mice: a hydrophobic peptide of a mitochondrially encoded protein. Cell (1990) 2.64
CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J Exp Med (1999) 2.53
Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med (1999) 2.42
Human immunodeficiency virus infection of monocytic and T-lymphocytic cells: receptor modulation and differentiation induced by phorbol ester. Virology (1987) 2.30
Productive infection and cell-free transmission of human T-cell leukemia virus in a nonlymphoid cell line. Science (1983) 2.26
CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes. J Exp Med (2001) 2.26
Loss of IFN-gamma production by invariant NK T cells in advanced cancer. J Immunol (2001) 2.20
Actin-containing matrix associated with the plasma membrane of murine tumour and lymphoid cells. Nature (1981) 2.12
Radiologic diagnosis and surgical treatment of urethral diverticulum in women. A reappraisal of voiding cystourethrography and positive pressure urethrography. J Reprod Med (2000) 2.10
Diverse TCRs recognize murine CD1. J Immunol (1999) 2.01
Expression of murine CD1 on gastrointestinal epithelium. Science (1990) 2.00
Mice lacking expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate delayed but enhanced T cell immune responses. J Exp Med (2001) 1.90
A randomized prospective trial of intrarectal lidocaine for pain control during transrectal prostate biopsy: the Emory University experience. J Urol (2000) 1.82
Expression of a nonpolymorphic MHC class I-like molecule, CD1D, by human intestinal epithelial cells. J Immunol (1991) 1.75
Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology (2000) 1.75
Human intestinal intraepithelial lymphocytes are derived from a limited number of T cell clones that utilize multiple V beta T cell receptor genes. J Immunol (1993) 1.71
Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner. Mol Endocrinol (2001) 1.71
Tumor susceptibility gene 101 protein represses androgen receptor transactivation and interacts with p300. Cancer (1999) 1.65
Functional characterization of mutant androgen receptors from androgen-independent prostate cancer. Clin Cancer Res (1997) 1.62
Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med (1992) 1.61
Detection of clonal immunoglobulin gene rearrangements by polymerase chain reaction amplification and single-strand conformational polymorphism analysis. Am J Pathol (1993) 1.56
NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J Immunol (2001) 1.52
CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation. J Immunol (1996) 1.49
A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses. J Immunol (2001) 1.47
CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes. Immunology (2000) 1.46
Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients. Lupus (1996) 1.44
CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J Leukoc Biol (2001) 1.44
Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium. Proc Natl Acad Sci U S A (2001) 1.43
Characterisation of Fasciola species from Mainland China by ITS-2 ribosomal DNA sequence. Vet Parasitol (2004) 1.36
Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor. Am J Pathol (1999) 1.36
Human T-cell receptor (TCR) alpha/beta + CD4-CD8- T cells express oligoclonal TCRs, share junctional motifs across TCR V beta-gene families, and phenotypically resemble memory T cells. Proc Natl Acad Sci U S A (1993) 1.32
CD1d is involved in T cell-intestinal epithelial cell interactions. J Exp Med (1993) 1.31
Tailgut cyst with malignancy: MR imaging findings. AJR Am J Roentgenol (1998) 1.29
Synapsin I is structurally similar to ATP-utilizing enzymes. EMBO J (1998) 1.27
SRY interacts with and negatively regulates androgen receptor transcriptional activity. J Biol Chem (2001) 1.26
Vgamma4(+) T cells promote autoimmune CD8(+) cytolytic T-lymphocyte activation in coxsackievirus B3-induced myocarditis in mice: role for CD4(+) Th1 cells. J Virol (2002) 1.24
MHC class Ib-restricted CTL provide protection against primary and secondary Listeria monocytogenes infection. J Immunol (2000) 1.23
Reversal of incipient brain death from head-injury apnea at the scene of accidents. N Engl J Med (1979) 1.23
The majority of H2-M3 is retained intracellularly in a peptide-receptive state and traffics to the cell surface in the presence of N-formylated peptides. J Exp Med (1999) 1.22
Human T cells expressing an invariant V alpha 24-J alpha Q TCR alpha are CD4- and heterogeneous with respect to TCR beta expression. Hum Immunol (1997) 1.22
CD1d-specific NK1.1+ T cells with a transgenic variant TCR. J Immunol (2000) 1.22
H2-M3, a full-service class Ib histocompatibility antigen. Annu Rev Immunol (1997) 1.19
Tissue distribution of the non-polymorphic major histocompatibility complex class I-like molecule, CD1d. Immunology (1993) 1.18
Shape separation of nanometer gold particles by size-exclusion chromatography. Anal Chem (1999) 1.18
A multi-institutional phase ii study of SU101, a platelet-derived growth factor receptor inhibitor, for patients with hormone-refractory prostate cancer. Clin Cancer Res (2001) 1.18
Regulation of selective protein degradation in the endoplasmic reticulum by redox potential. J Biol Chem (1993) 1.15
Tissue distribution, regulation and intracellular localization of murine CD1 molecules. Mol Immunol (1998) 1.14
Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia. Mod Pathol (2000) 1.14
Gamma interferon production is critical for protective immunity to infection with blood-stage Plasmodium berghei XAT but neither NO production nor NK cell activation is critical. Infect Immun (1999) 1.13
Cutting edge: the Ets1 transcription factor is required for the development of NK T cells in mice. J Immunol (2000) 1.12
Biochemical characterization of CD1d expression in the absence of beta2-microglobulin. J Biol Chem (1999) 1.12
Maternally transmitted antigen of mice: a model transplantation antigen. Annu Rev Immunol (1991) 1.11
Structure and function of the CD1 family of MHC-like cell surface proteins. Immunol Rev (1995) 1.11
Budd-Chiari syndrome caused by obstruction of the hepatic inferior vena cava: immediate and 2-year treatment results of transluminal angioplasty and metallic stent placement. Cardiovasc Intervent Radiol (1996) 1.09
The critical role of LIGHT, a TNF family member, in T cell development. J Immunol (2001) 1.09
Androgen receptor-associated protein complex binds upstream of the androgen-responsive elements in the promoters of human prostate-specific antigen and kallikrein 2 genes. Nucleic Acids Res (1997) 1.08
Distribution of dominant T cell receptor beta chains in human intestinal mucosa. J Exp Med (1994) 1.07
Immunolocalization of CD1d in human intestinal epithelial cells and identification of a beta2-microglobulin-associated form. Int Immunol (1999) 1.07
Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease. J Immunol (1996) 1.06
Induction of M3-restricted cytotoxic T lymphocyte responses by N-formylated peptides derived from Mycobacterium tuberculosis. J Exp Med (2001) 1.05
Evidence of T cell receptor beta-chain patterns in inflammatory and noninflammatory bowel disease states. Am J Physiol (1999) 1.03
A pathogenic role of IL-12 in blood-stage murine malaria lethal strain Plasmodium berghei NK65 infection. J Immunol (1998) 1.02
The selection of M3-restricted T cells is dependent on M3 expression and presentation of N-formylated peptides in the thymus. J Exp Med (1999) 1.00
IFN-gamma modulates CD1d surface expression on intestinal epithelia. Am J Physiol (1996) 0.99
Heterogeneity of NK1.1+ T cells in the bone marrow: divergence from the thymus. J Immunol (1999) 0.98
Intraepithelial lymphocytes in normal human intestine do not express proteins associated with cytolytic function. Am J Pathol (1997) 0.98
Reduced T helper 1 responses in IL-12 p40 transgenic mice. J Immunol (1998) 0.97
Expression of CD40 and CD40 ligand among cell populations within rheumatoid synovial compartment. Autoimmunity (2001) 0.97
Nonclassical behavior of the mouse CD1 class I-like molecule. J Immunol (1997) 0.97
Expression of CTLA-4 molecule in peripheral blood T lymphocytes from patients with systemic lupus erythematosus. J Clin Immunol (1998) 0.96
Tapasin enhances peptide-induced expression of H2-M3 molecules, but is not required for the retention of open conformers. J Immunol (2001) 0.95
Efficacy and safety of memantine, an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey. Surv Ophthalmol (2001) 0.95
Expression of CD1d2 on thymocytes is not sufficient for the development of NK T cells in CD1d1-deficient mice. J Immunol (1999) 0.95
Targeting steroid hormone receptor pathways in the treatment of hormone dependent cancers. Curr Pharm Biotechnol (2004) 0.95
A critical tyrosine residue in the cytoplasmic tail is important for CD1d internalization but not for its basolateral sorting in MDCK cells. J Immunol (1999) 0.95
Adiponectin signals in prostate cancer cells through Akt to activate the mammalian target of rapamycin pathway. Endocr Relat Cancer (2007) 0.94
Frequent abnormalities of TSG101 transcripts in human prostate cancer. Oncogene (1997) 0.94
Sequence analysis of the first internal transcribed spacer of rDNA supports the existence of the intermediate Fasciola between F. hepatica and F. gigantica in mainland China. Parasitol Res (2007) 0.94
Measurement of synovial tumor necrosis factor-alpha in diagnosing emergency patients with bacterial arthritis. Am J Emerg Med (1997) 0.93
Androgen regulation of soluble guanylyl cyclasealpha1 mediates prostate cancer cell proliferation. Oncogene (2006) 0.93